Effectiveness of the uPatient Platform in Prophylactic Treatment in Hemophilia

Real Fundación Victoria Eugenia

Status: Unknown

Conditions: Haemophilia

Treatments: Other: Patients with haemophilia

Study type: Observational

Funder types: Other; Industry

Identifiers

NCT02581735

uPatient

Details and patient eligibility

About

Research project whose main objective is to evaluate the use of a technology platform (uPatient) to register the prophylactic treatment of patients with hemophilia treated in different Hematology and Hemotherapy services of several hospitals in Spain.

Full description

The data obtained in this project will identify the level of compliance to the pharmacological treatment of patients with hemophilia prophylaxis. They will use different psychosocial questionnaires based on scientific evidence and the reliability of these, as well as its specific design for patients with hemophilia. Clinical data were also obtained regarding the joint of patients participating in the study state.

Enrollment: 40 estimated patients

Sex: Male

Ages: 13 to 50 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients diagnosed with hemophilia A or B
• Patients over 13 years old
• Patients on prophylactic treatment.

Exclusion criteria

• Patients who do not sign the informed consent document
• Patients who do not make domiciliary self-treatment
• Patients who do not have good adhesion to prophylactic treatment

Trial design

40 participants in 1 patient group

Patients with haemophilia

Description:

Using the platform Upatient, patients with hemophilia will register for one year, the prophylactic treatment who receive at home. Likewise, they indicate a replacement therapy as a result of joint bleeds. At baseline, a month, 6 months and at the end of the study, patients shall complete two questionnaires. The same way in the initial evaluation and end of the study, the clinical joint status will be evaluated with HJHS scale .

Treatment:

Other: Patients with haemophilia